Elucidating the role of SERINC5 in SARS-CoV-2 infection
Elucidating the role of SERINC5 in SARS-CoV-2 infection
批准号:
10372283
负责人:
Spyridon Stavrou
金额:
$23.93万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-18 至 2024-04-30
关键词:
2019-nCoVACE2Acute Respiratory Distress SyndromeAdultAffectBindingBiogenesisBiological AssayCOVID-19 therapeuticsCell fusionCellsCessation of lifeComplexCoronavirusCoughingDataDevelopmentDrug TargetingEventFamilyFeverGenomeGoalsHIVHIV-1HumanInfectionIntegral Membrane ProteinIntegration Host FactorsMalaiseMapsMediatingMolecular BiologyMultiple Organ FailureMutateMutationNamesParvovirusPersonsPhosphatidylserinesPlayPneumoniaProtein FamilyProteinsResearchResourcesRespiratory FailureRetroviridaeRetroviridae InfectionsReverse TranscriptionRoleSARS coronavirusSARS-CoV-2 antiviralSARS-CoV-2 infectionSARS-CoV-2 inhibitorSeriesSerineShortness of BreathSphingolipidsSurfaceTimeViralViral GenomeViral ProteinsVirusVirus DiseasesVirus Replicationantiviral drug developmentcommon symptominsightmembermutantnovelpandemic diseasepathogenic virusreceptorreceptor bindingtargeted treatmenttherapeutic developmenttherapeutic targetviral entry inhibitor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A viral pathogen associated with severe pneumonia was recently identified as the cause of a global pandemic that has resulted in the death of over two million people. This viral pathogen was later classified as a coronavirus that was subsequently named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Currently, there is a paucity of information regarding SARS-CoV-2 infection and the cellular factors associated with it. The identification of host factors that target SARS-CoV-2 infection and the elucidation of their mechanism of action is critical for the development of SARS-CoV-2 therapeutics. It was recently shown that the Serine Incorporator (SERINC) protein family, which is comprised by 5 multipass transmembrane proteins (SERINC1-5) plays a critical role in retroviral entry, yet the role of SERINC factors on other viral infections including SARS-CoV-2 infection is currently unknown. This proposal investigates the effect of SERINC5 on SARS-CoV-2 infection. The goal of this proposal is to provide mechanistic evidence on the effect of SERINC5 on SARS-CoV-2 entry, as many times, host factors use different mechanisms to restrict viruses that belong to different viral families. Previous research has shown that human immunodeficiency virus (HIV) is potently restricted by SERINC5 in a mechanism that has not been fully elucidated. However, HIV encodes an accessory protein, Nef, which counteracts the deleterious effect of SERINC5. Similar viral proteins have been identified in other retroviruses, which demonstrates the importance of SERINC5 in retrovirus infection. Hence another aspect of this proposal is to determine a SARS-CoV-2 encoded factor that targets SERINC5 and the mechanism it utilizes to counteract SERINC5. This study will provide much needed insight into the role of a novel host factor that targets SARS- CoV-2, which is of great importance as there is not a lot of mechanistic understanding of host factors that target SARS-CoV-2. Moreover, little is known about the role of SARS-CoV-2 proteins and how they modulate the host cell; hence, the findings of this proposal will provide valuable information regarding the function of SARS-CoV-2 encoded factors. Finally, the discovery of host factors that restrict SARS-CoV-2 infection may expand the gamut of potential drug targets for the development of SARS-CoV-2 antivirals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the role of SERINC5 in SARS-CoV-2 infection
-
批准号:10624238
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2022
-
负责人:Spyridon Stavrou
-
依托单位:
MARCH Proteins, Members of a Host Protein Family that Targets HIV
-
批准号:10402690
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2021
-
负责人:Spyridon Stavrou
-
依托单位:
MARCH Proteins, Members of a Host Protein Family that Targets HIV-1
-
批准号:10455259
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2021
-
负责人:Spyridon Stavrou
-
依托单位:
MARCH Proteins, Members of a Host Protein Family that Targets HIV
-
批准号:10543550
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2021
-
负责人:Spyridon Stavrou
-
依托单位:
The role of SERINC5 during retrovirus infection in vivo
-
批准号:10082429
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2020
-
负责人:Spyridon Stavrou
-
依托单位:
The role of SERINC5 during retrovirus infection in vivo
-
批准号:9887341
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2020
-
负责人:Spyridon Stavrou
-
依托单位:
The in vivo function of A3A and A3G during retrovirus infection
-
批准号:8456554
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2013
-
负责人:Spyridon Stavrou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: